Navigation Links
NASA pinpoints causes of 2011 Arctic ozone hole
Date:3/11/2013

A combination of extreme cold temperatures, man-made chemicals and a stagnant atmosphere were behind what became known as the Arctic ozone hole of 2011, a new NASA study finds.

Even when both poles of the planet undergo ozone losses during the winter, the Arctic's ozone depletion tends to be milder and shorter-lived than the Antarctic's. This is because the three key ingredients needed for ozone-destroying chemical reactions chlorine from man-made chlorofluorocarbons (CFCs), frigid temperatures and sunlight are not usually present in the Arctic at the same time: the northernmost latitudes are generally not cold enough when the sun reappears in the sky in early spring. Still, in 2011, ozone concentrations in the Arctic atmosphere were about 20 percent lower than its late winter average.

The new study shows that, while chlorine in the Arctic stratosphere was the ultimate culprit of the severe ozone loss of winter of 2011, unusually cold and persistent temperatures also spurred ozone destruction. Furthermore, uncommon atmospheric conditions blocked wind-driven transport of ozone from the tropics, halting the seasonal ozone resupply until April.

"You can safely say that 2011 was very atypical: In over 30 years of satellite records, we hadn't seen any time where it was this cold for this long," said Susan E. Strahan, an atmospheric scientist at NASA Goddard Space Flight Center in Greenbelt, Md., and main author of the new paper, which was recently published in the Journal of Geophysical Research-Atmospheres.

"Arctic ozone levels were possibly the lowest ever recorded, but they were still significantly higher than the Antarctic's," Strahan said. " There was about half as much ozone loss as in the Antarctic and the ozone levels remained well above 220 Dobson units, which is the threshold for calling the ozone loss a 'hole' in the Antarctic so the Arctic ozone loss of 2011 didn't constitute an ozone hole."

The majority of o
'/>"/>

Contact: Maria-Jose Vinas
maria-jose.vinasgarcia@nasa.gov
301-614-5883
NASA/Goddard Space Flight Center
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Culturally sensitive research in United Arab Emirates pinpoints indoor air quality risks
2. Its in the genes: Research pinpoints how plants know when to flower
3. Computer model pinpoints prime materials for efficient carbon capture
4. U OF A expert pinpoints nutrient behind fresh water algae blooms
5. University of Maryland School of Medicine, NIH study pinpoints brain areas role in learning
6. Research pinpoints key gene for regenerating cells after heart attack
7. Study pinpoints, prevents stress-induced drug relapse in rats
8. Record-breaking grant: New research project to investigate the causes of mental disorders
9. Long-term research reveals causes and consequences of environmental change
10. Glycogen accumulation in neurons causes brain damage and shortens the lives of flies and mice
11. Zebrafish provide insights into causes and treatment of human diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NASA pinpoints causes of 2011 Arctic ozone hole
(Date:4/27/2015)... -- For more than four decades, AUVSI,s Unmanned Systems ... worldwide event for the unmanned land, sea, and air ... any local, national, or trade news organization interested in ... current applications of unmanned technologies. The conference will explore ... industry, and how it will soon impact the lives ...
(Date:4/20/2015)... -- Huntington Memorial Hospital is the first facility in ... wireless monitoring sensor to manage heart failure (HF). The ... heart failure monitoring device that has been proven to ... manage heart failure. The CardioMEMS HF System ... artery (PA) during a non-surgical procedure to directly measure ...
(Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... time have assessed dolphin and porpoise populations around the ... gear and recommended nine urgent priorities for action in ... nine projects highlight species threatened by bycatch that will ... to languish without intervention. , The list of dolphins ...
... time have assessed dolphin and porpoise populations around the ... gear and recommended nine urgent priorities for action in ... nine projects highlight species threatened by bycatch that will ... to languish without intervention. , The list of dolphins ...
... at blink-of-the-eye speeds by squirting chemicals called neurotransmitters across ... lots of different receptors and neurotransmitters work simultaneously. Which ... reported in the July 20 issue of the Journal ... led by David Featherstone, a University of Illinois at ...
Cached Biology News:Canada's first embryonic stem cell lines 2Canada's first embryonic stem cell lines 3Leading scientists rank endangered dolphins, porpoises most in need of immediate action 2Leading scientists rank endangered dolphins, porpoises most in need of immediate action 3UIC researchers show protein routes messages in nerve cells 2
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... VANCOUVER , May 21, 2015 /PRNewswire/ - ... a clinical stage regenerative medicine company focused on ... an upcoming poster presentation at the International Society ... treatment for chronic Achilles tendinosis currently in a ... on May 29 th from 5:30 PM ...
(Date:5/20/2015)... 20, 2015 Veracyte, Inc . ... demonstrating the ability of the company,s molecular classifier ... other interstitial lung diseases (ILDs) using samples obtained ... to help thousands of patients avoid invasive, risky ... diagnosis – a frequent challenge for physicians and ...
(Date:5/20/2015)... , May 19, 2015 Research and Markets ... the "Global Cell Therapy Market Outlook 2020 " ... cell therapy in tissue and regenerative medicine is expected ... other options which could help in the growth of ... segment but they are unable to form new tissue ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
... + 10% and +12%... -- re> ANTONY, France, October 14, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
... announces that a new market research report is available ... http://www.reportlinker.com/p0312814/ Photovoltaic-Technology-Roadmap.html ... source of clean and renewable energy is the main ... have agreed on a 20% renewable energy target by ...
... ... ... ... keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result = ...
Cached Biology Technology:STALLERGENES : Significant Growth : Q3 2010 + 10% and +12% Over the First 9 Months / Shionogi Partnership: First EUR24 Million Instalment 2STALLERGENES : Significant Growth : Q3 2010 + 10% and +12% Over the First 9 Months / Shionogi Partnership: First EUR24 Million Instalment 3STALLERGENES : Significant Growth : Q3 2010 + 10% and +12% Over the First 9 Months / Shionogi Partnership: First EUR24 Million Instalment 4STALLERGENES : Significant Growth : Q3 2010 + 10% and +12% Over the First 9 Months / Shionogi Partnership: First EUR24 Million Instalment 5STALLERGENES : Significant Growth : Q3 2010 + 10% and +12% Over the First 9 Months / Shionogi Partnership: First EUR24 Million Instalment 6STALLERGENES : Significant Growth : Q3 2010 + 10% and +12% Over the First 9 Months / Shionogi Partnership: First EUR24 Million Instalment 7STALLERGENES : Significant Growth : Q3 2010 + 10% and +12% Over the First 9 Months / Shionogi Partnership: First EUR24 Million Instalment 8STALLERGENES : Significant Growth : Q3 2010 + 10% and +12% Over the First 9 Months / Shionogi Partnership: First EUR24 Million Instalment 9Reportlinker Adds Photovoltaic Technology Roadmap 2Reportlinker Adds Photovoltaic Technology Roadmap 3Reportlinker Adds Photovoltaic Technology Roadmap 4The World Market for Diabetes Treatments Now Available at ReportsandReports 2The World Market for Diabetes Treatments Now Available at ReportsandReports 3The World Market for Diabetes Treatments Now Available at ReportsandReports 4The World Market for Diabetes Treatments Now Available at ReportsandReports 5The World Market for Diabetes Treatments Now Available at ReportsandReports 6The World Market for Diabetes Treatments Now Available at ReportsandReports 7The World Market for Diabetes Treatments Now Available at ReportsandReports 8The World Market for Diabetes Treatments Now Available at ReportsandReports 9